Clinical trials
Observational Critical Illness trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 6 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Unknown status | 8 |
| Recruiting | 6 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Medical Center Groningen | 11 |
| Amsterdam UMC, location VUmc | 4 |
| Radboud University Medical Center | 4 |
| Leiden University Medical Center | 3 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2 |
| Catharina Ziekenhuis Eindhoven | 2 |
| Frisius Medisch Centrum | 2 |
| ARH van Zanten, MD PhD | 1 |
| Gelderse Vallei Hospital | 1 |
| Karolinska University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Critical Illness | 33 |
| Acute Disease | 3 |
| Shock | 3 |
| Bacterial Infections | 2 |
| Candidiasis, Invasive | 2 |
| Respiratory Insufficiency | 2 |
| Sepsis | 2 |
| Shock, Septic | 2 |
| Acute Kidney Injury | 1 |
| Asthenia | 1 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.